Submitted by Anonymous (not verified) on 6 August 2026 - 16:44
Human medicines European public assessment report (EPAR): Tenkasi (previously Orbactiv), oritavancin, Date of authorisation: 19/03/2015, Revision: 17, Status: Authorised
Source: